Cellular health
Cellular health

NAD+ & Glutathione

NAD+ injectionNAD+ nasal sprayGlutathione injectionGlutathione nasal spray

Metabolic

MetforminLow dose naltrexone

Lipotropics & Energy

MICC-B12Lipo+ B6
Peptides
Peptides

Growth & recovery

Sermorelin injectionSermorelin lozenge

Skin & wellness

GHK-cu cream
Weight management
Weight management

GLP-1 — injectable

Mounjaro® (tirzepatide)Zepbound® (tirzepatide)Ozempic® (semaglutide)Wegovy® (semaglutide)

GLP-1 — oral

Wegovy® pill (semaglutide)Foundayo™ (orforglipron)
How it works
Sign in + Get started
Home Protocols Zepbound® (tirzepatide)
Zepbound® (tirzepatide)
Weight management

Zepbound® (tirzepatide)

Prefilled pen, subcutaneous

$750/mo

Activates GIP and GLP-1 receptors to help regulate appetite, increase feelings of fullness, and support long-term weight management.

  • A dual GIP/GLP-1 receptor agonist that acts on appetite-regulating pathways
  • FDA-approved for long-term weight management in eligible adults
  • Prescribed and monitored by a licensed provider
Get started

Includes provider review · Ships in 3–5 days if prescribed

  • Licensed providers
  • Free shipping
  • US-based pharmacies

Zepbound® is an FDA-approved branded prescription medication dispensed by a licensed pharmacy; it is not compounded. It is prescribed only if a licensed provider determines that it is clinically appropriate following an evaluation. Elysium Health is not a clinical provider but contracts with third-party clinical entities with licensed health care providers which provide medical care to individuals that use the Elysium Health platform. Image for illustration only; actual product presentation may vary.

Safety info: Zepbound is used to treat obesity or overweight with weight-related health conditions, along with diet and exercise. It may cause serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). See important safety information.

Why Zepbound®

A dual-hormone approach to weight management

20.9 % average body weight lost in a 72-week clinical trial *

Tirzepatide activates GIP and GLP-1 receptors—two pathways involved in appetite regulation and metabolic function. Zepbound® is FDA-approved to help eligible adults lose excess weight and maintain weight loss, alongside a reduced-calorie diet and increased physical activity.

Select your current weight 220 lbs
Weight you could lose 46 lbs

*Based on a 72-week clinical trial of non-diabetic adults with obesity, or overweight with at least one weight-related condition, in which participants on the highest dose of Zepbound® lost an average of 20.9% of their body weight, compared with 3.1% for participants taking placebo. All participants followed a reduced-calorie diet and increased physical activity. Individual results vary.

Get started

Illustrative calculator based on published Phase 3 trial averages; it is not a prediction or guarantee of individual results. Individual responses vary from person to person; no specific outcomes are guaranteed.

How Zepbound® works

What it does in the body

Tirzepatide acts on two hormone pathways at once, under a licensed provider's plan.

Targets two pathways

Tirzepatide activates both GIP and GLP-1 receptors, hormones involved in appetite and blood-sugar regulation.

Supports appetite regulation

Zepbound® can reduce appetite and food intake and increase feelings of fullness.

Supports long-term weight management

Medication is used alongside a reduced-calorie diet, increased physical activity, and provider-guided care.

Our medical team

Developed with expert clinicians

Omar Baker, M.D., F.A.A.P., Elysium Chief Medical Officer

From our Chief Medical Officer

The goal of longevity treatment is not simply more years. It is more good years. We built TELI to bring clinical rigor to a space that has too often lacked it, so people can pursue their healthspan with the same confidence they bring to the rest of their medical care.
Omar Baker, M.D., F.A.A.P., Elysium Chief Medical Officer

How The Elysium Longevity Institute works

From intake to your doorstep

  1. Completing a TELI intake from home
    Step 1

    Complete your medical intake

    Choose your protocol, then share your health history and goals to begin your longevity care.

    What your provider needs

  2. A licensed provider reviewing an intake
    Step 2

    Provider review

    A licensed provider will review your intake and prescribe a personalized protocol, if appropriate.

    Licensed & confidential

  3. A TELI shipment on a doorstep
    Step 3

    Shipped to your door

    If prescribed, a licensed partner pharmacy will ship to your door free of charge within 3–5 business days.

    Fast, free shipping

  4. Messaging a provider through the TELI portal
    Step 4

    Ongoing care

    Message your provider any time through your TELI portal.

    On-demand support

+Get started today

FAQ

Frequently asked questions

What is Zepbound®?

Zepbound® is an FDA-approved prescription medication containing tirzepatide, a GIP and GLP-1 receptor agonist. Along with a reduced-calorie diet and increased physical activity, it is used to help eligible adults with obesity or overweight lose weight and keep it off.

Is Zepbound® the same as Mounjaro®?

Zepbound® and Mounjaro® contain the same active ingredient, tirzepatide, but are approved for different uses. Zepbound® is FDA-approved for chronic weight management, while Mounjaro® is FDA-approved to improve blood sugar control in adults with type 2 diabetes.

How do you take Zepbound®?

Zepbound® is injected under the skin once weekly. The autoinjector is a prefilled, single-use pen. If prescribed, your provider and pharmacy will give you exact dosing and administration instructions.

What are the side effects of Zepbound®?

Common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, injection-site reactions, fatigue, burping, hair loss, and acid reflux. Gastrointestinal side effects may be more noticeable when starting treatment or increasing the dose. Contact your healthcare provider if a side effect is severe, does not go away, or is bothersome.

Who shouldn't take Zepbound®?

Zepbound® should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC), people with multiple endocrine neoplasia syndrome type 2 (MEN 2), or anyone who has had a serious allergic reaction to tirzepatide or another ingredient in Zepbound®. Zepbound® is not recommended for people with severe gastroparesis. Tell your provider if you are pregnant or planning to become pregnant, take insulin or certain diabetes medications, or have a history of pancreas, gallbladder, kidney, or diabetic eye problems. Zepbound® should be discontinued if pregnancy occurs. Your provider will review your medical history before prescribing.

See all questions

Zepbound® is FDA-approved for chronic weight management. No specific outcomes are guaranteed; individual results may vary.

Zepbound® is a registered trademark of Eli Lilly and Company. The Elysium Longevity Institute is not affiliated with, endorsed by, or sponsored by Eli Lilly.

You may also like

Explore other treatments

  • Wegovy® (semaglutide)
    Weight management

    Wegovy® (semaglutide)

    Prefilled pen, subcutaneous · $580/mo

    View
  • Mounjaro® (tirzepatide)
    Weight management

    Mounjaro® (tirzepatide)

    Prefilled pen, subcutaneous · $1,620/mo

    View
  • Ozempic® (semaglutide)
    Weight management

    Ozempic® (semaglutide)

    Prefilled pen, subcutaneous · $780/mo

    View

Ready to start Zepbound® (tirzepatide)?

Complete your intake online. A licensed provider will review your information and, if eligible, prescribe a personalized plan.

Get started

Zepbound® (tirzepatide)

$750/mo · Prefilled pen, subcutaneous

Get started

Personalized longevity care, guided by licensed providers.

Protocols

Cellular health Peptides Weight management

Company

How it works Scientific Advisory Board About Elysium

Support

Contact us FAQ BMI calculator Help center

Legal

Important Safety Information Privacy Policy Consumer Health Data Privacy Policy Terms of Service Your Privacy Choices

The information provided on this website is for general educational purposes only and is not medical advice. Elysium Health is not a clinical provider but contracts with third-party clinical entities with licensed health care providers which provide medical care to individuals that use the Elysium Health platform. Those providers determine whether treatment is clinically appropriate. Prescription products are available only upon evaluation and, if prescribed, fulfillment by a licensed pharmacy. Certain medications are compounded pursuant to a valid prescription and are not reviewed or approved by the FDA for safety, effectiveness, or quality. Individual results may vary. No specific outcomes are guaranteed. This service is not for medical emergencies — if you are experiencing an emergency, call 911.

© 2026 TELI by Elysium Health. All rights reserved.